THCV
Tetrahydrocannabivarin

How it occurs

A propyl analog of THC found in some cultivars, generally at low levels.

Relationship to other cannabinoids

Propyl analog related to THC; activity is dose- and context-dependent.

What is established

THCV interacts with cannabinoid signaling differently depending on dose and context.

Commonly reported effects

Energy and appetite claims are common in marketing; they are not settled clinical conclusions.

Anecdotal or marketing-led unless stated otherwise

What remains uncertain

Claims about energy, appetite, or weight loss are not settled and should not be marketed as proven.

Evidence quality

Early human and preclinical evidence.

Safety and potential interactions

Human safety and interaction evidence remains limited; intoxicating potential may vary with dose.

Vaporization relevance

Heating can change cannabinoid form and delivery, but laboratory boiling points do not define a universal device setting. Heater design, sensor position, airflow, material, load, and draw behavior all affect exposure. This entry makes no compound-specific temperature recommendation.

Legal and regulatory context

May face differing interpretations depending on source and chemical relationship to THC.

Dated source foundation

Direct authoritative sources reviewed 2026-08-20. These sources support the safety and regulatory boundaries of this draft; a scientific editor must still verify compound-specific claims against current peer-reviewed literature.

• FDA — Cannabis and cannabis-derived products: questions and answers ↗
• FDA — What to know about cannabis and CBD products ↗
• NIDA — Cannabis (Marijuana) ↗
• CDC — Cannabis frequently asked questions ↗

Related entries

THC · CBDV

← All encyclopedia entries